DarioHealth (DRIO) Director Dennis Matheis Buys $100K Stock

What Happened

• Dennis Matheis, a director of DarioHealth (DRIO), reported two types of transactions. On August 12, 2024 he was party to automatic conversions of Series B preferred securities into common stock (reported as 965 common shares acquired at an attributed price of $19.10, value $18,432, and a related derivative disposition of 50 preferred shares shown with a $50,000 value). On July 23, 2026 he purchased 14,430 shares at $6.93 per share for $100,000 (acquired).
• The July 2026 trade is a direct purchase (a clear buy); the August 2024 items were automatic conversions of preferred into common (a corporate conversion event, not an open-market sale).

Key Details

• Transaction dates and amounts:
  • 2024-08-12: Conversion of Series B preferred into common — 965 common shares acquired @ $19.10 (total $18,432). A related derivative entry shows 50 preferred shares with a $50,000 disposition value (see footnotes).
  • 2026-07-23: Purchase of 14,430 shares @ $6.93 = $100,000 (purchased pursuant to a Securities Purchase Agreement dated July 22, 2026).
• Shares owned after transactions:
  • Footnote states Matheis beneficially owned 28,596 shares immediately after the August 12, 2024 conversion. Adding the July 23, 2026 purchase would bring reported beneficial ownership to about 43,026 shares per the filing (assuming no other changes).
• Notable footnotes:
  • F1: Series B preferred automatically converted on its 15-month anniversary, subject to a non‑waivable 19.99% ownership blocker.
  • F2: The reported conversion details reflect a reverse stock split and dividend adjustments (50 Series B‑2 preferred converted into many common shares, reported post-split as 965 common shares).
  • F3: The 2026 purchase was made under a Securities Purchase Agreement at $6.93/share.
• Filing timeliness:
  • The Form 4 was filed on July 28, 2026. That is late relative to the August 12, 2024 conversion and the July 23, 2026 purchase (Form 4s are generally due within 2 business days), so this filing was not timely.

Context

• Automatic conversions of preferred stock to common are corporate events (not discretionary buys or sales by the insider) and often reflect the terms of the security (here including an ownership blocker and dividend provisions).
• The July 2026 transaction is a purchase (a more informative signal to investors than a routine conversion or tax-withholding sale) and was executed via a purchase agreement rather than an open-market one-off trade.
• All statements above are factual summaries from the Form 4 and its footnotes; they do not attempt to infer Matheis’s motivations.